P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England
Jones D., Shakir R., Candio P., Ramroth J., Wolstenholme J., Gray A., Cutter D., Ntentas G.